Canton Strategic Holdings (CNTN) Accounts Payables (2020 - 2026)
Canton Strategic Holdings (CNTN) posted Accounts Payables of $402311.0 for Q1 2026, down 63.1% on a QoQ basis from $1.1 million in Q4 2025, and down 52.0% year-over-year from $838184.0 in Q1 2025.
Canton Strategic Holdings (CNTN) Accounts Payables (2020 - 2026) Analysis & Trends
Canton Strategic Holdings' Accounts Payables history runs 7 years deep, the most recent figure standing at $402311.0 for Q1 2026.
- Quarterly Accounts Payables fell 52.0% year-over-year to $402311.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $402311.0 (down 52.0% YoY) and the FY2025 annual result came in at $1.1 million, changed 0.06% from the prior year.
- Accounts Payables was $402311.0 for Q1 2026 at Canton Strategic Holdings, down from $1.1 million in the prior quarter.
- Across five years, Accounts Payables topped out at $1.1 million in Q2 2023 and bottomed at $100000.0 in Q2 2025.
- A 5-year average of $782106.2 and a median of $784029.0 in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables jumped 112.11% — and 2025, when it slumped 87.25%.
- Canton Strategic Holdings' Accounts Payables stood at $954505.0 in 2022, then decreased by 4.81% to $908577.0 in 2023, then climbed by 19.93% to $1.1 million in 2024, then increased by 0.06% to $1.1 million in 2025, then slumped by 63.1% to $402311.0 in 2026.
- Business Quant data shows CNTN's Accounts Payables at $402311.0 in Q1 2026, $1.1 million in Q4 2025, and $659254.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | 402,311.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 402,311.00 |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 659,254.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 838,184.00 |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | 783,839.00 |
| Jun 30, 2024 | 784,029.00 |
| Mar 31, 2024 | 993,244.00 |
| Dec 31, 2023 | 908,577.00 |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 718,990.00 |
| Dec 31, 2022 | 954,505.00 |
| Sep 30, 2022 | 536,838.00 |
| Jun 30, 2022 | 559,529.00 |
| Mar 31, 2022 | 597,455.00 |
| Dec 31, 2021 | 1.46 Mn |
| Dec 31, 2020 | 514,828.00 |